Overview

WEED, Inc. is a company working on various business opportunities in the cannabis and hemp industry, including indoor and outdoor cultivation, product development, processing, and manufacturing of both pharmaceutical and non-pharmaceutical products, services, therapeutics, and treatments on a global scale for the medical cannabis and hemp markets. The company’s long-term goals include finding cures for many diseases and ailments using the Cannabaceae plant and its derivatives.

In November 2021, WEED completed the purchase of the Sugar Hill Golf course property in New York, which includes access to Lake Erie water and wastewater management infrastructure. The company plans to utilize this property to enter the hemp and infused beverage markets, and may potentially develop a luxury cannabis-friendly condominium and resort project in the future.

WEED has also established subsidiaries in Australia (WEED Australia Ltd. and the Cannabis Institute of Australia) and Israel (WEED Israel Cannabis Ltd.) to conduct cannabis and hemp research, develop products, and potentially expand into the Oceania, Asian, and global legal cannabis markets.

In May 2022, WEED acquired Hempirical Genetics, LLC, which provides the company with a diverse inventory of over 200 high-THC strains, 15 “pure” landrace strains, and 30+ CBD and CBG strains. WEED believes that combining these precise cannabinoid strains can achieve desired medical outcomes.

Financial Performance

WEED has not generated any revenue since its inception, as it is still in the research and development stage of its operations. The company’s comprehensive net loss increased from $170,635 in the three months ended March 31, 2024, to $440,380 in the three months ended March 31, 2025, primarily due to increases in general and administrative expenses and professional fees.

General and administrative expenses increased from $136,565 to $383,268, mainly due to increases in consulting services and salaries. Professional fees also increased from $25,203 to $45,847, largely related to legal and accounting services, as well as stock-based compensation.

WEED’s cash balance decreased from $159,355 as of December 31, 2024, to $3,142 as of March 31, 2025, due to the company’s operating losses and lack of revenue. The company’s total assets decreased from $738,366 to $575,128, while its total liabilities decreased from $959,372 to $921,364 during the same period.

Strengths and Weaknesses

Strengths:

• Diverse inventory of cannabis strains, including high-THC, landrace, and CBD/CBG varieties, which can be used to develop targeted medical products
• Established subsidiaries in Australia and Israel to conduct research and potentially expand into new markets
• Acquisition of the Sugar Hill Golf course property provides access to water resources and potential for future development

Weaknesses:

• No revenue generation since inception, relying on financing to fund operations
• Significant operating losses and cash burn rate, with limited cash on hand
• Dependence on continued financing from shareholders and other related parties to fund operations

Outlook

WEED’s long-term plan is to become a “Seed-to-Sale” global holding company, providing infrastructure, financial solutions, product development, and real estate options in the emerging legal cannabis and hemp markets. The company aims to build a globally recognized brand and conduct research, marketing, import/export, and manufacturing of proprietary products on an international level.

However, the company’s ability to achieve these goals is heavily dependent on its ability to secure additional financing, as it currently does not generate any revenue and has a significant cash burn rate. WEED will need to continue borrowing from shareholders and other related parties, and/or raise money from the sales of its securities, to fund its ongoing operations and future growth initiatives.